Celldex Therapeutics CLDX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's total current assets?
- Celldex Therapeutics (CLDX) reported total current assets of $459.22M in Q1 2026.
- How has Celldex Therapeutics's total current assets changed year-over-year?
- Celldex Therapeutics's total current assets decreased by 33.8% year-over-year, from $693.76M to $459.22M.
- What is the long-term trend for Celldex Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Celldex Therapeutics's total current assets has grown at a 22.0% compound annual growth rate (CAGR), from $197.84M to $534.66M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.